{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:47:34Z","timestamp":1793850454295,"version":"4.6.1"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.1001\/jamacardio.2021.1720","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T17:30:25Z","timestamp":1621099825000},"page":"1032","source":"Crossref","is-referenced-by-count":58,"title":["Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention"],"prefix":"10.1001","volume":"6","author":[{"given":"Birgit","family":"Vogel","sequence":"first","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Department of Cardiology, The University of Oklahoma Health Sciences Center, Oklahoma City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"St Francis Hospital, Roslyn, New York"},{"name":"Cardiovascular Research Foundation, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Florida College of Medicine, Jacksonville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Farhan","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridhima","family":"Goel","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Briguori","sequence":"additional","affiliation":[{"name":"Mediterranea Cardiocentro, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Collier","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland"},{"name":"Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos and Complutense University, Calle del Prof Martin Lagos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gil","sequence":"additional","affiliation":[{"name":"Department of Invasive Cardiology, Center of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ling","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, Liaoning Sheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra","family":"Kaul","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Batra Hospital and Medical Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Kornowski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell W.","family":"Krucoff","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Duke University Medical Center\u2013Duke Clinical Research Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kunadian","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University and Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamir R.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hamilton Health Sciences, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moliterno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Duke University Medical Center\u2013Duke Clinical Research Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Sardella","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Policlinico Umberto I University, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Witzenbichler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Helios Amper-Klinikum, Dachau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Gibson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Pocock","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wilhelminenhospital, Vienna, Austria"},{"name":"Sigmund Freud University, Medical Faculty, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"23","key":"hoi210037r1","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"hoi210037r2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI.","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"hoi210037r3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamacardio.2019.4296","article-title":"Association of sex with outcomes in patients undergoing percutaneous coronary intervention: a subgroup analysis of the GLOBAL LEADERS randomized clinical trial.","volume":"5","author":"Chichareon","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"9","key":"hoi210037r4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cjca.2012.11.013","article-title":"Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data.","volume":"29","author":"Mrdovic","year":"2013","journal-title":"Can J Cardiol"},{"key":"hoi210037r5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ahj.2016.09.006","article-title":"Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: rationale and design of the TWILIGHT study.","volume":"182","author":"Baber","year":"2016","journal-title":"Am Heart J"},{"issue":"23","key":"hoi210037r6","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"hoi210037r7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7326\/0003-4819-115-4-256","article-title":"Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), phase II trial.","volume":"115","author":"Bovill","year":"1991","journal-title":"Ann Intern Med"},{"issue":"10","key":"hoi210037r8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.","volume":"329","author":"GUSTO investigators","year":"1993","journal-title":"N Engl J Med"},{"issue":"11","key":"hoi210037r9","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"16","key":"hoi210037r10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction.","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"hoi210037r11","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"hoi210037r12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ccd.26606","article-title":"Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: results from the PROMETHEUS study.","volume":"89","author":"Chandrasekhar","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"hoi210037r13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000523","article-title":"Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.","volume":"3","author":"Hess","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"hoi210037r14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ccd.v85.3","article-title":"Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial.","volume":"85","author":"Yu","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"hoi210037r15","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0285","article-title":"Sex-based outcomes in patients with a high bleeding risk after percutaneous coronary intervention and 1-month dual antiplatelet therapy: a secondary analysis of the LEADERS FREE randomized clinical trial.","author":"Mehran","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"21","key":"hoi210037r16","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk.","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"issue":"24","key":"hoi210037r17","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial.","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"hoi210037r18","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial.","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"issue":"23","key":"hoi210037r19","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial.","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"issue":"10151","key":"hoi210037r20","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"hoi210037r21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jacc.2019.11.056","article-title":"Ticagrelor with or without aspirin after PCI: the TWILIGHT platelet substudy.","volume":"75","author":"Baber","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"hoi210037r22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","article-title":"Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention.","volume":"66","author":"G\u00e9n\u00e9reux","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"hoi210037r23","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jacc.2015.01.047","article-title":"Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention.","volume":"65","author":"Kazi","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"hoi210037r24","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.jacc.2017.02.029","article-title":"Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting.","volume":"69","author":"Palmerini","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"hoi210037r25","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jcin.2016.04.009","article-title":"Time-dependent associations between actionable bleeding, coronary thrombotic events, and mortality following percutaneous coronary intervention: results from the PARIS registry.","volume":"9","author":"Baber","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"hoi210037r26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ahj.2014.07.012","article-title":"Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.","volume":"168","author":"Othman","year":"2014","journal-title":"Am Heart J"},{"issue":"6","key":"hoi210037r27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/2048872615610884","article-title":"Editor\u2019s choice\u2014gender difference in prognostic impact of in-hospital bleeding after myocardial infarction - data from the SWEDEHEART registry.","volume":"5","author":"Holm","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"4","key":"hoi210037r28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ahj.2013.07.014","article-title":"Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial.","volume":"166","author":"Kaul","year":"2013","journal-title":"Am Heart J"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2779977\/jamacardiology_vogel_2021_oi_210037_1631046571.08152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:02:23Z","timestamp":1631545343000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2779977"}},"subtitle":["A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2021.1720","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}